Aristotle University Of Thessaloniki (AUTH)
Πειραματική μελέτη αναστολής του σχηματισμού μετεγχειρητικών ενδοπεριτοναϊκών συμφύσεων
Abstract
dc:descriptionThis experimental study was undertaken in the context of research to prevent adhesion formation; it investigates, for the first time, the anti-adhesive action of: a) activated drotrecogin alpha (Xigris®, Lilly); b) beractant (Survanta®, Abbott); and c) their combination. Xigris is a recombinant form of human activated protein C, which has anti-thrombotic, anti-apoptotic, anti-inflammatory and profibrinolytic properties. Beractant is a pulmonary surfactant intended for intra-tracheal use, which is indicated for prevention and treatment of respiratory distress syndrome in premature infants. The selection of these factors was made on the basis of their properties, action and characteristics. For the purposes of the experiment were used 40 female New Zealand white rabbits, randomly distributed into four groups of ten. The animals underwent median sub-umbilical laparotomy under general anesthesia and adhesion formation was induced by standard lesions of defined areas on the right ventral parietal peritoneum, the serosa of cecum and colon and the right uterine horn. The first group was the control group and no substance was administered intra-peritoneally. The second group received activated drotrecogin alpha (Xigris®, Lilly), the third group the exogenous surfactant beractant (Survanta®, Abbott), while the fourth group received a combination of the two previous substances. Experimental animals were sacrificed after three weeks. The adhesions created were recorded, classified and graded in accordance with the descriptive system of classification and grading of the experimental model. Samples were taken for microscopic examination from all experimental animals. In cases where adhesions were formed, these were taken as a whole, with part of the surfaces enclosing them. In cases where no adhesions were formed, pieces of the areas had suffered lesions during the experimentation were taken. The macroscopic findings, microscopic and statistical analysis have led to the following conclusions: 1) Activated drotrecogin alpha (Xigris®, Lilly) administered intra-peritoneally had a significant anti-adhesive action. More specifically, this factor was found to be more effective in regard to: a) the number of solid-strong adhesions formed per experimental group; b) the adhesion attenuation process; and c) the participation of the right uterine horn. In one case the appearance of undesirable side-effect was attributed to the fibrolytic action of the substance. The cost reduced to the proposed regimen came to 38.2 €/kg body weight.2) The application of the exogenous surfactant beractant (Survanta®, Abbott) intra-peritoneally also led to significant reduction of post-surgical adhesions. More specifically, this factor was found to be effective in regard to: a) the number of solid-strong adhesions formed per experimental group; b) the overall severity of the lesion; and c) the full and homogenous serosa mesotheliosis. It caused no side-effects and the cost reduced to the proposed regimen came to 27.8 €/kg body weight. 3) The combination of the two factors did not show any advantage when compared to their individual administration. It is concluded that intra-peritoneal administration of the factors under investigation could be a reliable and safe solution in preventing post-surgical adhesions. More, extensive studies are necessary to confirm the results of this study in regard to the effectiveness and safety of the substances involved and, probably, to improve their use so as to achieve a more effective and ‘balanced’ anti-adhesive action, aiming at their further application on humans regardless of age.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Σβήρκος, Μενέλαος
Subjects
dc:subject × 12- Ενδοπεριτοναϊκές μετεγχειρητικές συμφύσεις
- Αναστολή
- Δροτρεκογίνη άλφα (XIGRIS)
- Επιφανειοδρατικός παράγοντας ( SURVANTA)
- Intra-abdominal post-operative adhesions
- Inhibition - reduction
- Drotrecogin alpha (XIGRIS)
- Surfactant ( SURVANTA)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26058